Overview

Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder

Status:
Terminated
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
This proposed study sets out to examine the antidepressant effects of tocilizumab among patients with treatment-refractory major depression.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital